Date posted: March 9, 2021, 6:00 am
In this episode, we will discuss basic pharmacology and use of naloxone, available formulations, evidence for its effectiveness, and naloxone-related pharmacy management and regulations.
Date posted: February 16, 2021, 6:00 am
In this episode, we chat with Morgan Anderson, PharmD, BCIDP and alumna of Â鶹ӰÒôMS, about Enterococcal infections including patterns of antimicrobial resistance and recommended treatment options.
Date posted: January 26, 2021, 6:00 am
In this episode, we will briefly review the clotting cascade and warfarin's mechanism of action, and then discuss warfarin pharmacogenetics implications and what clinical recommendations and tools are available in order to calculate warfarin dose.
Date posted: January 5, 2021, 6:00 am
In this episode, we discuss the FDA's Emergency Use Authorization (EUA) process and review the resources available to healthcare providers when an EUA for a drug therapy is approved.
Date posted: December 15, 2020, 6:00 am
In this episode, we interview the niece of Dr. Rosalind Franklin, the namesake of our university, who is also named Rosalind Franklin. As part of the university’s centennial celebration of Dr. Franklin, we discuss her amazing life and scientific achievements and reflect on how her story can be applied to our own lives.
Date posted: November 24, 2020, 6:00 am
In this episode, we discuss how to excel in your next journal club presentation or discussion while avoiding the all-too-common pitfalls for this unique format.
Date posted: November 3, 2020, 6:00 am
In this episode, we will discuss some of the interesting and unusual warfarin interactions such as acetaminophen, alcohol, agents with antiplatelet properties, non-green vitamin K foods, and CBD/THC.
Date posted: October 13, 2020, 6:00 am
In this episode, we discuss the pathophysiology, drug-related causes, diagnosis, and treatment of a common type of hyponatremia called the syndrome of inappropriate antidiuretic hormone (SIADH).
Date posted: September 22, 2020, 6:00 am
In this episode, we discuss the latest dyslipidemia treatment agent bempedoic acid and dive into its pharmacology, use, and clinical evidence.
Date posted: September 8, 2020, 6:00 am
In this episode, we discuss the proposed risks of using beta blockers in patients with cocaine use disorders and whether evidence supports this drug interaction as an “absolute” contraindication.